lexicon genetics incorporated

Lexicon Sub-licenses Knockout Mouse Technology

Lexicon Genetics Incorporated has granted a non-exclusive sublicense to Biogen, Inc. for the use of certain aspects of Lexicon’s positive- negative selection technology for the generation of knockout mice. Biogen will use the technology in its internal drug-discovery and target validation programs. Financial terms were not disclosed. Lexicon‘s positive-negative selection technology is one of the Read more about Lexicon Sub-licenses Knockout Mouse Technology[…]

lexicon genetics incorporated

Lexicon Genetics Grants Bristol-Myers Squibb Sublicense

Lexicon Genetics Incorporated has granted a non-exclusive sublicense to Bristol- Myers Squibb Company for the use of certain aspects of Lexicon’s positive-negative selection and isogenic DNA technologies. Bristol-Myers Squibb will use the technology for the generation of knockout mice for internal research purposes to gain predictive information about gene products that are valid drug targets Read more about Lexicon Genetics Grants Bristol-Myers Squibb Sublicense[…]